DeviceTalks Podcast Network - TopPodcast.com

View Top 200 Chart

Back to Rankings Page

DeviceTalks Podcast Network — Technology
DeviceTalks Podcast Network

The DeviceTalks Podcast Network is the ultimate destination for all things #MedTech. By subscribing to this single feed, you’ll gain access to every podcast in our diverse and growing portfolio—more than a dozen unique shows featuring senior leaders, groundbreaking technology insights, and in-depth discussions on the most important topics in the medical device industry.

Each episode dives deep into critical areas like business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and beyond. You’ll hear from leading voices at top companies—ranging from major OEMs to innovative startups—sharing their solutions, stories, and strategies for tackling the industry’s biggest challenges.

Our Lineup of Shows Includes:
• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neurovascular
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Enovis & Zimmer Biomet
• StrykerTalks

Why Subscribe?
Subscribing here means you’ll never miss an update from any of our shows. Whether you want a broad overview of the entire industry or prefer to tune into a specific series, this single feed has you covered.

If you discover a favorite topic, you can always subscribe to that individual show’s feed for a more tailored experience.

Meet Your Hosts:
• Tom Salemi, Editorial Director, DeviceTalks
• Kayleen Brown, Managing Editor, DeviceTalks

#DeviceTalks, Where Device Makers Connect.

Copyright: © All rights reserved

Latest Episodes:

S1 Ep 3 - ZB’s Lancaster talks next-gen knee systems, robotics & building a new regional powerhouse Aug 21, 2024

Show notes

In this episode of Ortho Innovation Talks, Jim Lancaster, President of Global Reconstruction at Zimmer Biomet, connects his deep roots in Warsaw, Indiana—known as the orthopedic capital of the world—with his current role in shaping the region's future as a global MedTech hub with his efforts to diversify the region's medtech industry, including the partnership with Plug and Play to attract new innovations in sensor technology and augmented reality, and by driving technical innovations at Zimmer Biomet. Additionally, Lancaster provides an in-depth look at the development of Persona IQ, the world's first smart knee system, which integrates advanced sensor technology to monitor patient recovery. He also discusses the growing importance of cementless fixation in knee implants, highlighting Zimmer Biomet's focus on enhancing implant longevity and patient outcomes. Lastly, Lancaster discusses Zimmer Biomet's role in surgical robotics, particularly the advancements brought by the Rosa robotics platform, which includes applications for knee, hip, and even shoulder surgeries. Please join us September 10-12th for DeviceTalks's LIVE Connected Health webinar series. Register at no cost: https://event.on24.com/wcc/r/4613481/E930EFFA706588C378BEAA97824C7CE2/5516160 Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to the Ortho Innovation Talks podcast, featuring Zimmer Biomet!

Daveen Chopra discusses Edwards’ mitral and tricuspid focus, PASCAL and EVOQUE, and patient impacts Aug 16, 2024

Show notes

In the inaugural episode of our newest podcast, Structural Heart Talks, we sit down with Daveen Chopra, Corporate VP and GM of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences. In the episode, Chopra discusses the unique challenges of advancing therapies for the mitral and tricuspid valves, which have historically been more difficult to treat than the aortic valve due to their complex and varied nature. He details Edwards Lifesciences' efforts to innovate in this space with technologies like the PASCAL valve repair system and the EVOQUE tricuspid valve replacement system, the first transcatheter tricuspid valve replacement approved in both the US and Europe. Later, Chopra explains the importance of a focused approach at Edwards Lifesciences, where the company’s specialization in structural heart disease enables deeper knowledge and more targeted innovation. The conversation also explores the intricate process of planning and executing these advanced procedures, which require close collaboration between interventional cardiologists and echocardiographers. Chopra underscores the ongoing commitment to clinical evidence and real-world outcomes as key drivers of future success in this rapidly evolving field. Looking ahead, he emphasizes the need to increase awareness, diagnosis, and treatment rates for valve diseases, noting that many patients still go untreated due to a lack of awareness. Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 Thank you for listening to the Structural Heart Talks podcast. Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks or the Structural Heart Talks on YouTube Podcasts to ensure you never miss an episode.

May Health VC and CEO give glimpse into promising startup, assessment of women’s health investments Aug 09, 2024

Show notes

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi delves into the opportunities in women’s health devices with Sofinnova Partners Managing Partner Antoine Papiernik and May Health CEO Anne Morrissey. Sofinnova invested in May Health, which is developing a device-based therapy for Polycystic ovary syndrome, a common cause of infertility. Is the financing environment for Women’s Health companies improving? What will drive investors to commit more capital. MassDevice Editor Chris Newmarker brings his Newmarker’s Newsmakers back featuring news from NeuroOne, Pentax, Allurion, Medtronic and Abbott. Associate Editor Sean Whooley joins the NewNew team to break down the new partnership between Abbott and Medtronic in the diabetes business. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Intuitive CMO Myriam Curet unpacks DaVinci 5 launch, growing robotics adoption, and clinical impact Aug 06, 2024

Show notes

In this episode of IntuitiveTalks, we welcome back Myriam Curet, MD, EVP & Chief Medical Officer at Intuitive, to discuss the transformative impact of surgical robotics on patient care, focusing on the evolution of the DaVinci system, including the recent DaVinci 5 launch. In the episode, Dr. Curet explains how surgical robotics like DaVinci have shifted from being seen as advanced technology to becoming an integral part of surgical practice, enhancing patient outcomes and surgeon efficiency. She also stresses the significance of real-world data and meta-analyses in validating surgical robotic systems and providing a profound understanding of their benefits across various categories of surgery. Lastly, Dr. Curet offers a behind-the-scenes look at the meticulous development and approval process of the DaVinci 5 system. Thank you to Paragon Medical for sponsoring this episode of IntuitiveTalks. Please visit https://www.paragonmedical.com/ to learn more about how Paragon Medical supports medical device companies. Thank you for listening to the IntuitiveTalks podcast. Please subscribe to DeviceTalks on all major podcast channels to never miss an episode.

How can the cloud and connected devices improve patient care? Insulet CEO Jim Hollingshead knows Aug 02, 2024

Show notes

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi interviews Jim Hollingshead, PhD, the CEO of Insulet. Hollingshead had the unenviable job of taking over for CEO Shacey Petrovic when she left the insulin-delivery company two years ago. Hollingshead previously had helped ResMed develop its industry-leading connectivity/cloud strategy. In this conversation you’ll hear about his journey and what steps Insulet has taken to build share in the Type 1 and Type 2 diabetes markets MassDevice Editor Chris Newmaker returns with his newsmakers - Asensus Surgical, Tandem, Stryker, Perceptive, and BiVacor. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don't miss a future episode.

New CEO Landon on the power of mentorship and the strategy behind expanding Natus Neuro DX platform Jul 26, 2024

Show notes

In this episode of the DeviceTalks Weekly, Chris Landon returns to the podcast but this time as CEO of Natus Neuro, a company building out a monitoring, diagnostics and data collection platform to help diagnose and treat neurological disorders. This episode is sponsored by DeviceTalks West. Host Tom Salemi and Chris Newmarker, editor of MassDevice, review this week’s Newmaker’s Newsmakers - aka the week’s biggest medtech stories. Top newsmakers include Imperative Care, the FDA, neuro start-Ups, Inspire Medical and Edwards Lifesciences. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.

Abbott’s Fishler on Dual Chamber Leadless Pacemaker from “submarine” tests to FDA approval Jul 23, 2024

Show notes

In this episode of AbbottTalks, Matthew Fishler, PhD, Chief Engineer & Senior Director, Product Development, Cardiac Rhythm Management at Abbott Cardiovascular, shares his experience helping to develop the revolutionary dual-chamber leadless pacemaker system, taking us through the significant challenges and triumphs of creating a device that ensures precise coordination between the heart’s atrial and ventricular chambers without traditional leads. Fishler recounts the meticulous development process, from initial concept testing using rudimentary "submarines" in saline tanks to achieving FDA approval. He highlights the deliberate approach taken to ensure safety and effectiveness, resulting in a device that now benefits patients with more comprehensive cardiac support. Lastly, he explains the innovative i2i communication technology, which uses electrical impulses to enable seamless device interaction, a concept likened to a “moonshot” due to its unprecedented nature. Thank you to ProMed for sponsoring this episode of AbbottTalks. To learn more about ProMed’s prototype services, visit: https://promedmolding.com/capabilities/prototyping/ Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

CEO Rowland shares how Endotronix will bring hope to heart patients following FDA Cordella approval Jul 19, 2024

Show notes

In this week’s DeviceTalks Weekly Podcast, Host Tom Salemi talks with Endotronix CEO Harry Rowland about the company’s long road to securing PMA approval from the FDA for its Cordella Pulmonary Artery (PA) Sensor System for the treatment of heart failure patients. But first we welcome back the Newmarker’s Newsmakers! MassDevice Editor-in-Chief Chris Newmarker highlights news from Masimo, Stryker, Medtronic, ICU Medical and Edwards Lifescience. This episode is sponsored by DeviceTalks West. Register to attend at West.DeviceTalks.com. Thank you for listening to the DeviceTalks Weekly podcast. Subscribe now to the DeviceTalks Podcast Network.

Stryker’s Pierce updates on Vocera, 1788, Neuro, & interest in soft-tissue surgical robotics system Jul 17, 2024

Show notes

In this episode of StrykerTalks, we welcome back Andy Pierce, Group President of MedSurg and Neurotechnology, to discuss the impact of the Vocera acquisition and how Vocera's dynamic clinical workflow addresses staffing shortages and enhances efficiency. Additionally, the episode covers Stryker's new LIFEPAK 35 monitor/defibrillator, advancements in the 1788 visualization platform, and ongoing innovations in the neurovascular space. Pierce also touches on plans for incorporating Vocera into more Stryker products and the company's interest in soft-tissue surgical robotics. Want more from Andy Pierce? Explore his previous appearances on the DeviceTalks Podcast Network. Prior appearance on StrykerTalks: https://www.devicetalks.com/pierce-talks-innovation-vocera-ascs-and-why-nurses-hug-strykers-neptune-waste-management-system/ Prior appearance on DT Weekly: https://www.devicetalks.com/lobo-and-pierce-talk-wright-cool-tech-robotics-and-the-not-so-secret-plans-to-keep-stryker-growing/ Thank you to S2 Insight, Inc. for sponsoring this episode. To learn more about how S2 Insight, Inc. supports medical device companies, visit https://www.s2insight.com/case-studies. Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

CEO Powell explains how RefleXion developed precise targeting system for cancer-killing radiotherapy Jul 12, 2024

Show notes

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiotherapy system used to combat cancer. Powell talks about his path into MedTech and how the company’s ScinTix system can “debulk” widespread cancer in patients. This episode is sponsored by the DeviceTalks West conference taking place Oct. 16-17 at the Santa Clara Convention Center. Register at West.DeviceTalks.com Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Related Podcasts